Top Industry Leaders in the Evans Syndrome Market
Latest Evans Syndrome Companies Updates:
Apellis Pharmaceuticals: Acquired Tioma Therapeutics, gaining access to their promising complement inhibitor for treating rare blood diseases, including Evans syndrome.
Travere Biopharmaceuticals: Partnered with Akcea Therapeutics to develop and commercialize pegcetacoplan for treating certain blood diseases, including Evans syndrome.
List of Evans Syndrome Key companies in the market:
- Pfizer, Merck & Co.
- Sanofi
- Astellas Pharma, Inc.
- GlaxoSmithKline plc
- Novartis AG
- Enzon Pharmaceuticals, Inc.
- Bayer AG
- Sigma-Aldrich
- Abbott Laboratories
- Eli Lily and Company
- BD
- ChemoMetec A/S